Andlauer Price To Sales Ratio from 2010 to 2024

AND Stock  CAD 43.25  0.14  0.32%   
Andlauer Healthcare Price To Sales Ratio yearly trend continues to be very stable with very little volatility. Price To Sales Ratio is likely to grow to 2.66 this year. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Andlauer Healthcare's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
2.64574589
Current Value
2.66
Quarterly Volatility
0.70436024
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Andlauer Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Andlauer Healthcare's main balance sheet or income statement drivers, such as Tax Provision of 16.2 M, Interest Income of 3 M or Depreciation And Amortization of 41 M, as well as many indicators such as Price To Sales Ratio of 2.66, Dividend Yield of 0.0079 or PTB Ratio of 3.47. Andlauer financial statements analysis is a perfect complement when working with Andlauer Healthcare Valuation or Volatility modules.
  
This module can also supplement various Andlauer Healthcare Technical models . Check out the analysis of Andlauer Healthcare Correlation against competitors.

Other Information on Investing in Andlauer Stock

Andlauer Healthcare financial ratios help investors to determine whether Andlauer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Andlauer with respect to the benefits of owning Andlauer Healthcare security.